1. Home
  2. FUND vs ARCT Comparison

FUND vs ARCT Comparison

Compare FUND & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FUND

Sprott Focus Trust Inc.

HOLD

Current Price

$10.04

Market Cap

291.7M

Sector

Finance

ML Signal

HOLD

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$7.65

Market Cap

224.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUND
ARCT
Founded
1988
2013
Country
Canada
United States
Employees
N/A
176
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
291.7M
224.8M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
FUND
ARCT
Price
$10.04
$7.65
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$38.44
AVG Volume (30 Days)
33.5K
401.4K
Earning Date
01-01-0001
06-08-2026
Dividend Yield
6.64%
N/A
EPS Growth
N/A
20.00
EPS
0.93
N/A
Revenue
N/A
$82,031,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.21
$5.85
52 Week High
$10.16
$24.14

Technical Indicators

Market Signals
Indicator
FUND
ARCT
Relative Strength Index (RSI) 62.95 49.83
Support Level $8.08 $7.00
Resistance Level N/A $7.88
Average True Range (ATR) 0.16 0.51
MACD -0.02 0.01
Stochastic Oscillator 76.72 48.39

Price Performance

Historical Comparison
FUND
ARCT

About FUND Sprott Focus Trust Inc.

Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, The Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: